NVIDIA
NVDA
Adobe
ADBE
Netflix
NFLX
Alphabet-A
GOOGL
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 3.780
- -0.090-2.33%
Trading Dec 30 13:39 ET
259.11MMarket Cap-0.99P/E (TTM)
3.920High3.730Low249.73KVolume3.830Open3.870Pre Close945.43KTurnover0.59%Turnover Ratio5.40P/E (Static)68.55MShares19.94952wk High1.32P/B160.24MFloat Cap1.57552wk Low--Dividend TTM42.39MShs Float41.930Historical High--Div YieldTTM4.91%Amplitude1.575Historical Low3.785Avg Price1Lot Size
About Amylyx Pharmaceuticals Company
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.
Company Profile
SymbolAMLX
Company NameAmylyx Pharmaceuticals
Listing DateJan 7, 2022
Issue Price19.00
Founded2013
MarketNASDAQ
Employees384
Fiscal Year Ends12-31
Address43 Thorndike Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02141
Phone1-617-682-0917
Websitehttp://www.amylyx.com
Company Executives
- Name
- Position
- Salary
- Joshua Cohen
- Co-Chief Executive Officer and Director
- 7.42M
- Justin Klee
- Co-Chief Executive Officer and Director
- 7.42M
- Dr. Camille L. Bedrosian,M.D.
- Chief Medical Officer
- 2.37M
- Gina M. Mazzariello
- Chief Legal Officer and General Counsel
- 3.01M
- James M. Frates
- Chief Financial Officer and Principal Accounting Officer
- 3.51M
- Dr. George Mclean Milne, Jr,PhD
- Chairman of the Board
- 385.07K
- Dr. Bernhardt G. Zeiher, F.A.C.P.,F.C.C.P.,M.D.
- Director
- --
- Karen Firestone
- Independent Director
- 681.15K
- Paul Fonteyne, M.S.
- Independent Director
- 342.12K
- Daphne E. Quimi
- Independent Director
- 348.59K
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.